Organogenesis Holdings Inc (NAS:ORGO)

$ 2.83 -0.1 (-3.41%) Market Cap: 375.19 Mil Enterprise Value: 398.15 Mil PE Ratio: 0 PB Ratio: 1.42 GF Score: 75/100

Q4 2023 Organogenesis Holdings Inc Earnings Call Transcript
Feb 29, 2024

$3.57 (+2.29%)

Earnings
Q3 2023 Organogenesis Holdings Inc Earnings Call Transcript
Nov 09, 2023

$1.97 (-3.90%)

Earnings
Organogenesis Holdings Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 11, 2023
Q2 2023 Organogenesis Holdings Inc Earnings Call Transcript
Aug 09, 2023

$3.39 (-8.38%)

Earnings
Q1 2023 Organogenesis Holdings Inc Earnings Call Transcript
May 10, 2023

$2.1 (-5.41%)

Earnings
Q4 2022 Organogenesis Holdings Inc Earnings Call Transcript
Mar 01, 2023

$2.28 (-6.94%)

Earnings
Q3 2022 Organogenesis Holdings Inc Earnings Call Transcript
Nov 09, 2022

$3.09 (-4.04%)

Earnings
Organogenesis Holdings Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 13, 2022
Q2 2022 Organogenesis Holdings Inc Earnings Call Transcript
Aug 09, 2022

$6.01 (-6.53%)

Earnings
Q1 2022 Organogenesis Holdings Inc Earnings Call Transcript
May 10, 2022

$5.53 (-1.60%)

Earnings
Q4 2021 Organogenesis Holdings Inc Earnings Call Transcript
Mar 01, 2022

$7.24 (-2.69%)

Earnings
Organogenesis Holdings Inc at Credit Suisse Healthcare Conference (Virtual) Transcript
Nov 11, 2021
Q3 2021 Organogenesis Holdings Inc Earnings Call Transcript
Nov 09, 2021

$11.4 (-3.06%)

Earnings
Organogenesis Holdings Inc at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (Virtual) Transcript
Sep 20, 2021
Organogenesis Holdings Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 14, 2021
Q2 2021 Organogenesis Holdings Inc Earnings Call Transcript
Aug 09, 2021

$14.82 (+0.68%)

Earnings
Q1 2021 Organogenesis Holdings Inc Earnings Call Transcript
May 10, 2021

$19.29 (-8.79%)

Earnings
Q4 2020 Organogenesis Holdings Inc Earnings Call Transcript
Mar 16, 2021

$17.06 (-0.81%)

Earnings
Organogenesis Holdings Inc Annual Shareholders Meeting Transcript
Dec 18, 2020
Q3 2020 Organogenesis Holdings Inc Earnings Call Transcript
Nov 09, 2020

$4.15 (+3.49%)

Earnings
Organogenesis Holdings Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 16, 2020
Q2 2020 Organogenesis Holdings Inc Earnings Call Transcript
Aug 10, 2020

$3.85 (-4.23%)

Earnings
Q1 2020 Organogenesis Holdings Inc Earnings Call Transcript
May 11, 2020

$3.78 (-1.31%)

Earnings
Q4 2019 Organogenesis Holdings Inc Earnings Call Transcript
Mar 09, 2020

$3.09 (-11.97%)

Earnings
Q3 2019 Organogenesis Holdings Inc Earnings Call Transcript
Nov 12, 2019

$7.52 (+2.31%)

Earnings
Q2 2019 Organogenesis Holdings Inc Earnings Call Transcript
Aug 09, 2019

$4.27

Earnings
Q1 2019 Organogenesis Holdings Inc Earnings Call Transcript
May 10, 2019

$7.01 (-0.14%)

Earnings

Organogenesis Holdings Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 13, 2022 / 03:45PM GMT

Release Date Price: $3.47 (-7.47%)

Transcript

Andrew Christopher Ranieri

Morgan Stanley, Research Division - Equity Analyst

Welcome to another session. I'm Drew Ranieri one of the medical device analyst here at Morgan Stanley. And I'm delighted to have members of the Organogenesis management team with us here today. Gary the CEO and Dave, the CFO. Maybe just before we kind of jump in I have to read the quick disclaimer but for important disclosures please see the Morgan Stanley Research disclosure website at morganstanley.com/researchdisclosures. And if you do have any other questions, please reach out to your Morgan Stanley sales rep. With that let's kind of kick it off. And Gary, maybe just spend a couple of minutes to kind of give some introductory comments and really set the stage for where the company plays its markets and really the growth opportunities that you see for the company?

Questions & Answers

Gary S. Gillheeney

Organogenesis Holdings Inc. - President, CEO & Director

Appreciate the opportunity. So Organogenesis, we're a med tech company. Primarily our technology is in the

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.